Ramakrishna G, Anderson L M
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702, USA.
Carcinogenesis. 1998 Mar;19(3):463-70. doi: 10.1093/carcin/19.3.463.
Mutational activation of the K-ras oncogene often occurs in human and mouse lung adenocarcinomas. Since K-ras p21 functions in trans-membrane signaling, we have investigated whether the amount of this protein in lung cell membranes is a variable that could influence lung tumorigenesis, either due to genetic differences or in response to tumor promoters. The six mouse strains assessed showed little difference in the total lung K-ras p21 after immunoprecipitation and immunoblotting. However, amount of ras p21 in the membrane fraction showed significant differences, with C57BL/6 and BALB/c having 3-5-fold more than NIH Swiss, AKR and DBA mice. Interestingly, a congenic AKR strain having the Ahr(b-1) Ah receptor allele from C57BL/6 mice (designated AKR.B6Ah) had high lung membrane K-ras p21 similar to that of C57BL/6. To test for possible changes related to lung tumor promotion, mice were treated with a promotional dose of TCDD (5 nmol/kg). After 48 h C57BL/6 lungs showed an increase in p21 in both total and membrane fractions. BALB/c, DBA and Swiss mice showed an increase only in membranes. There was no change in the AKR and AKR.B6Ah. Aroclor 1254 (250 mg/kg) caused an increase in membrane/cytosol ratio in Swiss mice. Thus the membrane:cytosol K-ras p21 ratio may be influenced by the Ahr phenotype, and TCDD and PCBs can induce p21 or increase its membrane level in certain strains, but these properties are not fully dependent on Ahr receptor type. In confirmation of the relevance of these findings for the tumor target cell type, the immortalized alveolar type 2 E10 cell line presented K-ras p21 in membrane, and this was increased 4-fold by treatment with 10 nM TCDD.
K-ras癌基因的突变激活在人类和小鼠肺腺癌中经常发生。由于K-ras p21在跨膜信号传导中起作用,我们研究了肺细胞膜中这种蛋白质的含量是否是一个可变因素,它可能由于遗传差异或对肿瘤启动子的反应而影响肺肿瘤发生。经免疫沉淀和免疫印迹评估的六个小鼠品系在总肺K-ras p21方面几乎没有差异。然而,膜部分中ras p21的含量显示出显著差异,C57BL/6和BALB/c比NIH瑞士小鼠、AKR和DBA小鼠多3至5倍。有趣的是,携带来自C57BL/6小鼠的Ahr(b-1) Ah受体等位基因的近交系AKR品系(命名为AKR.B6Ah)具有与C57BL/6相似的高肺膜K-ras p21。为了测试与肺肿瘤促进相关的可能变化,用促癌剂量的TCDD(5 nmol/kg)处理小鼠。48小时后,C57BL/6肺的总部分和膜部分中的p21均增加。BALB/c、DBA和瑞士小鼠仅在膜中出现增加。AKR和AKR.B6Ah没有变化。Aroclor 1254(250 mg/kg)导致瑞士小鼠的膜/胞质溶胶比率增加。因此,膜:胞质溶胶K-ras p21比率可能受Ahr表型影响,TCDD和多氯联苯可以在某些品系中诱导p21或增加其膜水平,但这些特性并不完全依赖于Ahr受体类型。为了证实这些发现与肿瘤靶细胞类型的相关性,永生化的肺泡II型E10细胞系在膜中呈现K-ras p21,用10 nM TCDD处理后增加了4倍。